Can a simple shot replace monthly IV for kidney transplant patients?
NCT ID NCT04955366
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study looks at whether kidney transplant patients can safely switch from a monthly IV drug called belatacept to a self-injected drug called abatacept. The goal is to see if kidney function stays the same or improves. About 87 adults who had a kidney transplant at least 2 years ago and are currently on belatacept will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL TRANSPLANT RECIPIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital (EUH)
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.